Influence of clinical trial participation on anti-thrombin use for patients with non-ST-segment elevation acute coronary syndromes: Patterns of enoxaparin vs. unfractionated heparin use in the CRUSADE initiative
Publication
, Journal Article
Shah, BR; Chen, AY; Peterson, ED; Mahaffey, KW; DeLong, ER; Ohman, EM; Pollack, CV; Gibler, WB; Roe, MT
Published in: CIRCULATION
May 29, 2007
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
May 29, 2007
Volume
115
Issue
21
Start / End Page
E583 / E583
Location
Washington, DC
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Shah, B. R., Chen, A. Y., Peterson, E. D., Mahaffey, K. W., DeLong, E. R., Ohman, E. M., … Roe, M. T. (2007). Influence of clinical trial participation on anti-thrombin use for patients with non-ST-segment elevation acute coronary syndromes: Patterns of enoxaparin vs. unfractionated heparin use in the CRUSADE initiative. CIRCULATION, 115(21), E583–E583.
Shah, Bimal R., Anita Y. Chen, Eric D. Peterson, Kenneth W. Mahaffey, Elizabeth R. DeLong, E Magnus Ohman, Charles V. Pollack, W Brian Gibler, and Matthew T. Roe. “Influence of clinical trial participation on anti-thrombin use for patients with non-ST-segment elevation acute coronary syndromes: Patterns of enoxaparin vs. unfractionated heparin use in the CRUSADE initiative.” CIRCULATION 115, no. 21 (May 29, 2007): E583–E583.
Shah BR, Chen AY, Peterson ED, Mahaffey KW, DeLong ER, Ohman EM, et al. Influence of clinical trial participation on anti-thrombin use for patients with non-ST-segment elevation acute coronary syndromes: Patterns of enoxaparin vs. unfractionated heparin use in the CRUSADE initiative. CIRCULATION. 2007 May 29;115(21):E583–E583.
Shah, Bimal R., et al. “Influence of clinical trial participation on anti-thrombin use for patients with non-ST-segment elevation acute coronary syndromes: Patterns of enoxaparin vs. unfractionated heparin use in the CRUSADE initiative.” CIRCULATION, vol. 115, no. 21, LIPPINCOTT WILLIAMS & WILKINS, May 2007, pp. E583–E583.
Shah BR, Chen AY, Peterson ED, Mahaffey KW, DeLong ER, Ohman EM, Pollack CV, Gibler WB, Roe MT. Influence of clinical trial participation on anti-thrombin use for patients with non-ST-segment elevation acute coronary syndromes: Patterns of enoxaparin vs. unfractionated heparin use in the CRUSADE initiative. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2007 May 29;115(21):E583–E583.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
May 29, 2007
Volume
115
Issue
21
Start / End Page
E583 / E583
Location
Washington, DC
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology